Skip to content

Author

Chrismawan Ardianto

We have 1 of 97 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

A Multi‐Scale Computational Framework for Anti‐Persister Tuberculosis Drug Discovery

A critically underexplored dimension, multi‐target drug discovery, is systematically examined, focusing on the design of dual‐pharmacophore inhibitors that simultaneously engage NDH‐2 and cytochrome bd oxidase, thereby raising the genetic barrier to resistance.

Said Moshawih, Anguraj Moulishankar, Chee-Yan Choo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.